FDA Warning Letter — BR SAS
The FDA took a Warning Letter action against BR SAS on Jun 8, 2018 (Suresnes, France). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action details
- Facility
- BR SAS
- Date
- Jun 8, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Suresnes (France)